Ground breaking clinical trial for blood cancer continues
Podcast |
Morning Report
Publisher |
Radio New Zealand
Media Type |
audio
Categories Via RSS |
News
Publication Date |
Jul 22, 2024
Episode Duration |
00:03:32
Sixty patients with the rare non-Hodgkin Lymphoma blood cancer, will be given CAR-T Cell therapy which reprogrammes their immune cells to recognise and kill cancer cells. Cancer patient David Down spoke to Ingrid Hipkiss.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review